By a News Reporter-Staff News Editor at Health& Medicine Week A patent application by the inventors Tupil, Srinath; Biggins, James; Bertolino, William, filed on July 21, 2014, was made available online on November 13, 2014, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned
Research and Markets has announced the addition of the "Active Pharmaceutical Ingredients Global Market- Forecast to 2020" report to their offering. Active Pharmaceutical Ingredients are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on
Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. In order to conduct educational and public information programs relating to tobacco use as authorized
Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, has entered into a Securities Purchase Agreement with Deerfield Management and certain of its affiliates pursuant to which Alimera will issue shares of preferred stock to Deerfield with a
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the addition of Steven Opal, M.D., an internationally recognized key opinion leader in the areas of pneumonia and sepsis, to the Company's scientific advisory board. Opal is a Professor of..
ALEXANDRIA, Va., Nov. 28 AstraZeneca Pharmaceuticals, Wilmington, Delaware, and Amylin Pharmaceuticals, San Diego, have been assigned a patent developed by 16 co-inventors for "GIP and exendin hybrid polypeptides." The co-inventors are Odile Esther Levy, San Diego, Alain D. Baron, San Diego, Lawrence J. D'Souza, San Diego, Mary Erickson, San Dieg
ALEXANDRIA, Va., Nov. 28 AstraZeneca Pharmaceuticals, Wilmington, Delaware, and Amylin Pharmaceuticals, San Diego, have been assigned a patent developed by six co-inventors for the "sustained release formulations using non-aqueous carriers." The co-inventors are Mary L. Houchin, Rockville, Maryland, Robin H. Lee, San Diego, Hong Qi, San Diego, Gr
On November 26, 2014, Avanir Pharmaceuticals, Inc. issued a press release announcing that the U.S. Food and Drug Administration has issued a Complete Response letter to its New Drug Application for AVP-825. A copy of the Press Release is filed herewith as Exhibit 99.1 and is incorporated by reference herein. Description 99.1 Press Release, dated No
Nov. 28 BioMarin agreed this week to buy Dutch biotech company Prosensa Holding N.V., a move intended to expand the Marin- based company's repertoire of drugs that fight rare diseases. It is under review by the U.S. Food and Drug Administration as is being fast-tracked for approval, BioMarin officials said. The deal also includes two additional $
ALEXANDRIA, Va., Nov. 28 Cephalon, Frazer, Pennsylvania, has been assigned a patent developed by Jason Edward Brittain, El Cajon, California, and Joe Craig Franklin, Tulsa, Oklahoma, for bendamustine pharmaceutical compositions. The patent application was filed on Dec. 19, 2012. Written by Sudarshan Harpal; edited by Jaya Anand.
Under the agreement, SII will develop and manufacture paediatric vaccines, Cipla will seek European Medicines Agency approval and market the products in Europe. This collaboration with SII enables Cipla to enter into the vaccines segment, continuing our commitment to inclusive healthcare for the world. Subhanu Saxena, MD& Global CEO, Cipla Limited
The patients will be treated at the Royal Brisbane and Women's Hospital and the Austin Hospital in Melbourne. x0D;. "The treatment involves an antibody that targets a cancer protein on the surface of tumour cells," Dr Day said x0D;. Dr Stringer said the upcoming GBM trial would be the first test of the drug against solid tumours, as opposed to
Highland Therapeutics Inc. is a specialty pharmaceutical company that, through its wholly owned subsidiary Ironshore Pharmaceuticals& Development, Inc., is leveraging its proprietary technology, DELEXIS?, to optimize the delivery of previously approved drug products. The Company's lead product candidates, HLD-200 and HLD-100, are novel formulatio
-Concordia Healthcare Corp.,, announced today a clinical trial and corporate update, including the status of patient enrollment in its Phase 3 clinical trial to treat a rare form of bile duct cancer, and the entering into of an exclusive trademark license and product distribution agreement for China and other Asian territories with Union Med.
The office bearers of PPMA have said that government should take positive measurers to promote pharma industry instead of harassing them. They strongly condemned violation of drug act and unlawful action taken by the Health Department. The meeting was attended by Mian Asad Shujaur Rehman, Khawaj Shahzeb Akram, Akbar Ali Bhatti, Amjad Ali Jawa and H
The update also mentioned that the results were published on Wednesday in the New England Journal of Medicine. "The safety profile is encouraging, as is the finding that the higher dose of vaccine induced an immune response quite comparable to that which has completely protected animals from Ebola," said Dr Anthony Fauci, Director of the US Nation
Ipsen today announced that the U.S. Food and Drug Administration has accepted for review its supplemental Biologics License Application for Dysport in the treatment of upper limb spasticity in adult patients. Marc de Garidel, Chairman and Chief Executive Officer of Ipsen stated The filing of Dysport in adult upper limb spasticity is an imp
Janssen Research& Development has submitted a new drug application for YONDELIS to the US Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma, including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline. We are particularly proud of this filing, as it...
New Pharmaceuticals market report from Global Markets Direct: " Medisyn Technologies, Inc.- Product Pipeline Review- 2014". Boston, MA 11/28/2014 Global Markets Direct's,' Medisyn Technologies, Inc.- Product Pipeline Review- 2014', provides an overview of the Medisyn Technologies, Inc.' s pharmaceutical research and development focus. This re
It will be months, at least, before a vaccine becomes available to tackle Ebola, experts have said as researchers reported success in early, safety tests with a leading candidate. A Phase I trial with the virus-based prophylactic carried by chimps showed it was "well-tolerated" by 20 healthy adults who generated antibodies and immune cells in respo
New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research. Boston, MA 11/28/2014 Global Markets Direct's,' IkerChem S.L.- Product Pipeline Review- 2014', provides an overview of the IkerChem S.L.' s pharmaceutical research and development focus. This report provides comprehensive information on
New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market ResearchBoston, MA 11/28/2014 Global Markets Direct's,' Orion Oyj- Product Pipeline Review- 2014', provides an overview of the Orion Oyj's pharmaceutical research and development focus. This report provides comprehensive information on the current
New Pharmaceuticals research report from FirstWord Pharma is now available from Fast Market ResearchBoston, MA 11/28/2014 Orphan Drug Market Access: Payer Insights on the Present and Future is a report that examines the regulation, pricing, reimbursement, players and stakeholder/payer interests that are shaping the current and future directio
Release date- 27112014- Switzerland and India,: Medicines for Malaria Venture signs collaboration agreements with two Indian pharmaceutical companies, Cipla Limited and Strides Arcolab Limited for the development of rectal artesunate for pre-referral treatment of children with severe malaria. Cipla and Strides will each develop a product building o
Essential drugs, or basic medicines, refers to a variety of medicines that are covered by the urban employee medical insurance in China. Merck Serono, a pharmaceutical company headquartered in Darmstadt, Germany, is actively involved in China's ongoing healthcare reforms, during which the essential drugs list is being revised. Allan Gabor, its pres